212 related articles for article (PubMed ID: 6911755)
1. Papanicolaou cervical smears for screening in asymptomatic women.
Barnes BA
Prim Care; 1981 Mar; 8(1):131-40. PubMed ID: 6911755
[TBL] [Abstract][Full Text] [Related]
2. [Pro or contra Papanicolaou cytologic smear every 3 years].
Delaloye JF; De Grandi P
Schweiz Med Wochenschr; 1998 Jun; 128(23):909-13. PubMed ID: 9658520
[TBL] [Abstract][Full Text] [Related]
3. Economic aspects of screening for cervical cancer in New Zealand.
Bethwaite J; Rayner T; Bethwaite P
N Z Med J; 1986 Oct; 99(811):747-51. PubMed ID: 3464889
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
Perovic S
J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
Koong SL; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
[TBL] [Abstract][Full Text] [Related]
6. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
[TBL] [Abstract][Full Text] [Related]
7. Screening for cervical cancer: will women accept less?
Sirovich BE; Woloshin S; Schwartz LM
Am J Med; 2005 Feb; 118(2):151-8. PubMed ID: 15694900
[TBL] [Abstract][Full Text] [Related]
8. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
Martin-Hirsch P; Rash B; Martin A; Standaert B
BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
10. Common problems in Papanicolaou smear interpretation.
DeMay RM
Arch Pathol Lab Med; 1997 Mar; 121(3):229-38. PubMed ID: 9111106
[TBL] [Abstract][Full Text] [Related]
11. [Population screening for uterine cervix cancer: the negative effects of insufficient knowledge as to what is normal and abnormal].
van der Graaf Y
Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1569-71. PubMed ID: 12224477
[TBL] [Abstract][Full Text] [Related]
12. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
13. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
Linder J; Zahniser D
Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
[TBL] [Abstract][Full Text] [Related]
14. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].
Jensen ML; Dybdahl H; Svanholm H
Ugeskr Laeger; 2000 May; 162(21):3024-7. PubMed ID: 10850190
[TBL] [Abstract][Full Text] [Related]
15. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
[TBL] [Abstract][Full Text] [Related]
16. Why women still die from cervical cancer.
Masood S
J Fla Med Assoc; 1997; 84(6):379-83. PubMed ID: 9379163
[TBL] [Abstract][Full Text] [Related]
17. [Cost-benefit analysis of the Program for Early Screening of Cervico-uterine Cancer].
Hernández-Peña P; Lazcano-Ponce EC; Alonso-de Ruiz P; Cruz-Valdez A; Meneses-González F; Hernández-Avila M
Salud Publica Mex; 1997; 39(4):379-87. PubMed ID: 9381251
[TBL] [Abstract][Full Text] [Related]
18. Utilization of obstetrician-gynecologists and prevention of cervical cancer.
Weisman CS; Celentano DD; Klassen AC; Rosenshein NB
Obstet Gynecol; 1987 Sep; 70(3 Pt 1):373-7. PubMed ID: 3627584
[TBL] [Abstract][Full Text] [Related]
19. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B
Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766
[No Abstract] [Full Text] [Related]
20. Cervical carcinoma in situ undetected by Papanicolaou smear but identified by cervicography. A case report.
Ferris DG
J Fam Pract; 1994 Jan; 38(1):74-7. PubMed ID: 8289055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
